Niagen Bioscience (NAGE) Return on Capital Employed Growth (5y) (2016 - 2025)
Niagen Bioscience (NAGE) Return on Capital Employed Growth (5y) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Niagen Bioscience |
280.11 Mn |
213.56 Mn |
19.98 Mn |
| Date | Value |
|---|
| Jun 30, 2025 |
13,728.00 |
| Mar 31, 2025 |
14,734.00 |
| Dec 31, 2024 |
13,492.00 |
| Sep 30, 2024 |
9,468.00 |
| Jun 30, 2024 |
16,390.00 |
| Mar 31, 2024 |
11,249.00 |
| Dec 31, 2023 |
9,323.00 |
| Sep 30, 2023 |
7,172.00 |
| Jun 30, 2023 |
3,896.00 |
| Mar 31, 2023 |
976.00 |
| Dec 31, 2022 |
-2,115.00 |
| Sep 30, 2022 |
-4,409.00 |
| Jun 30, 2022 |
-5,196.00 |
| Mar 31, 2022 |
-2,602.00 |
| Dec 31, 2021 |
-3,722.00 |
| Mar 31, 2018 |
4,606.00 |
| Dec 30, 2017 |
22,327.00 |
| Sep 30, 2017 |
13,456.00 |
| Dec 31, 2016 |
11,815.00 |
